Risk-Based Monitoring Software Market Size & Growth
The research undertaken by GME showed that the Global Risk-Based Monitoring Software Market is estimated to grow to a CAGR of 12.6 percent during the forecast period.The discovery of new diseases and the rising number of clinical trials and studies indicate a higher trajectory growth for the market evaluation. Also, the growing number of drug therapies in the clinical trial phase and the persistent need for regulatory approval for drug development further accentuates the importance of the software in assessing the risk of clinical trials. The considerable rising number of public and private investment in clinical trials indirectly lead to higher market demand in the aforementioned period.
Browse 155 Market Data
Tables and 117 Figures spread through 187 Pages and in-depth TOC on "Risk-Based Monitoring Software Market - Forecast to 2026"
By Type (Enterprise RMB Software, Site RBM
Software), By Component (Software, Services), By Delivery Mode (Web-Based,
Licensed Enterprise, Cloud-Based), By End User (Medical Device Companies,
Contract Research Organization, Pharmaceutical & Biopharmaceutical
Companies),By Region
(North America, Asia Pacific, CSA, Europe, and the Middle East and Africa);
End-User Landscape, Company Market Share Analysis & Competitor Analysis
Key Market Insights
·
The
growing number of drug therapies in the clinical trial phase and the persistent
need for regulatory approval for drug development further accentuates the
importance of the software in assessing the risk of clinical trials.
·
The enterprise RBM
software will hold the largest market share owing to the rising market
popularity in China.
·
The web-based software
division will hold a larger market share owing to the varied benefits offered
by the web-based software.
·
The key players
competing in this market are eClinical, Quanticate, JMP Clinical, Clue Points,
MasterControl, IBM Corporation, Anju Software, Bioclinica, and DATA TRACK among
others.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-risk-based-monitoring-software-market-2565
Type Outlook (Revenue, USD
Billion, 2020-2026)
·
Enterprise RMB Software
·
Site RBM Software
Component
Outlook (Revenue, USD
Billion, 2020-2026)
·
Software
·
Services
Delivery Mode Outlook (Revenue, USD Billion,
2020-2026)
·
Web-Based
·
Licensed Enterprise
·
Cloud-Based
End-User Outlook (Revenue, USD Billion,
2020-2026)
·
Medical Device Companies
·
Contract Research Organization
·
Pharmaceutical &Biopharmaceutical Companies
Regional Outlook (Revenue, USD Billion, 2020-2026)
North America
- The
U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest
of Europe
Asia Pacific
- China
- India
- Japan
- South
Korea
- Australia
- Rest
of APAC
Central & South America
- Brazil
- Argentina
- Rest
of CSA
Middle East & Africa
- Saudi
Arabia
- UAE
- Rest
of MEA
Contact:
Tracy Simon
Email
address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
Comments
Post a Comment